Next report date
Report period
Q4 2023
EPS estimate
—
Revenue estimate
—
0.55CNY
239.62 MCNY
1.01 BCNY
191.61 M
About BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD.
Sector
CEO
Jian Dong Yuan
Headquarters
Suzhou
Website
Employees (FY)
1.13 K
Founded
2001
ISIN
CNE100003PR1
FIGI
BBG00NV0D3S3
BrightGene Bio-Medical Technology Co., Ltd. engages in the research & development, and manufacturing of biopharmaceuticals, medicines as well as special generic active pharmaceutical ingredients and finished dosage forms. The company was founded by Yuan Jian Dong on October 26, 2001 and is headquartered in Suzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688166 is 28.70 CNY — it has increased by 0.63% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stocks are traded under the ticker 688166.
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
688166 stock is 2.32% volatile and has beta coefficient of 1.21. Check out the list of the most volatile stocks — is BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. there?
Yes, you can track BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. financials in yearly and quarterly reports right on TradingView.
688166 stock has risen by 10.77% compared to the previous week, the month change is a 4.01% fall, over the last year BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. has showed a 24.46% increase.
688166 net income for the last quarter is 82.35 M CNY, while the quarter before that showed 38.67 M CNY of net income which accounts for 112.95% change. Track more BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. financial stats to get the full picture.
Today BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. has the market capitalization of 11.53 B, it has increased by 3.12% over the last week.
Yes, 688166 dividends are paid annually. The last dividend per share was 0.11 CNY. As of today, Dividend Yield (TTM)% is 0.42%. Tracking BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. dividends might help you take more informed decisions.
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. dividend yield was 0.51% in 2022, and payout ratio reached 19.66%. The year before the numbers were 0.33% and 20.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 688166 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 1.13 K employees. See our rating of the largest employees — is BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. stock shows the neutral signal. See more of BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.